vs
Orthofix Medical Inc.（OFIX）とSUBURBAN PROPANE PARTNERS LP（SPH）の財務データ比較。上の社名をクリックして会社を切り替えられます
SUBURBAN PROPANE PARTNERS LPの直近四半期売上が大きい（$370.4M vs $219.9M、Orthofix Medical Inc.の約1.7倍）。SUBURBAN PROPANE PARTNERS LPの純利益率が高く（12.4% vs -1.0%、差は13.4%）。Orthofix Medical Inc.の前年同期比売上増加率が高い（2.0% vs -0.8%）。Orthofix Medical Inc.の直近四半期フリーキャッシュフローが多い（$16.8M vs $-67.5M）。過去8四半期でOrthofix Medical Inc.の売上複合成長率が高い（8.0% vs -13.8%）
オーソフィックスメディカル社は世界的な整形外科医療機器メーカーで、脊椎インプラント、整形外科用外傷治療製品、骨成長刺激療法機器、再生医療製品の開発・製造・販売を事業としています。北米、欧州、アジア太平洋を中心に整形外科医や医療機関向けに製品を提供し、筋骨格系疾患患者の治療成績向上に取り組んでいます。
Suburban Propane Partners LPは米国の大手エネルギー流通企業で、プロパンガス、天然ガス、暖房用油を中心に幅広いエネルギー製品を取り扱い、住宅、商業施設、工場、農業従事者向けにHVACシステムの設置・保守・修理サービスも提供しています。
OFIX vs SPH — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $219.9M | $370.4M |
| 純利益 | $-2.2M | $45.8M |
| 粗利率 | 71.1% | 64.7% |
| 営業利益率 | 0.2% | 18.3% |
| 純利益率 | -1.0% | 12.4% |
| 売上前年比 | 2.0% | -0.8% |
| 純利益前年比 | 92.4% | 135.7% |
| EPS（希薄化後） | $-0.05 | $0.69 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $219.9M | $370.4M | ||
| Q3 25 | $205.6M | $211.4M | ||
| Q2 25 | $203.1M | $260.1M | ||
| Q1 25 | $193.6M | $587.7M | ||
| Q4 24 | $215.7M | $373.3M | ||
| Q3 24 | $196.6M | $208.6M | ||
| Q2 24 | $198.6M | $254.6M | ||
| Q1 24 | $188.6M | $498.1M |
| Q4 25 | $-2.2M | $45.8M | ||
| Q3 25 | $-22.8M | $-35.1M | ||
| Q2 25 | $-14.1M | $-14.8M | ||
| Q1 25 | $-53.1M | $137.1M | ||
| Q4 24 | $-29.1M | $19.4M | ||
| Q3 24 | $-27.4M | $-44.6M | ||
| Q2 24 | $-33.4M | $-17.2M | ||
| Q1 24 | $-36.0M | $111.5M |
| Q4 25 | 71.1% | 64.7% | ||
| Q3 25 | 72.2% | 64.7% | ||
| Q2 25 | 68.7% | 61.7% | ||
| Q1 25 | 62.8% | 58.8% | ||
| Q4 24 | 69.0% | 60.6% | ||
| Q3 24 | 68.7% | 59.4% | ||
| Q2 24 | 67.8% | 62.9% | ||
| Q1 24 | 67.5% | 61.8% |
| Q4 25 | 0.2% | 18.3% | ||
| Q3 25 | -8.3% | -7.9% | ||
| Q2 25 | -7.9% | 2.1% | ||
| Q1 25 | -25.2% | 27.0% | ||
| Q4 24 | -5.3% | 15.8% | ||
| Q3 24 | -9.6% | -10.8% | ||
| Q2 24 | -12.5% | 3.2% | ||
| Q1 24 | -15.6% | 27.5% |
| Q4 25 | -1.0% | 12.4% | ||
| Q3 25 | -11.1% | -16.6% | ||
| Q2 25 | -6.9% | -5.7% | ||
| Q1 25 | -27.4% | 23.3% | ||
| Q4 24 | -13.5% | 5.2% | ||
| Q3 24 | -13.9% | -21.4% | ||
| Q2 24 | -16.8% | -6.8% | ||
| Q1 24 | -19.1% | 22.4% |
| Q4 25 | $-0.05 | $0.69 | ||
| Q3 25 | $-0.57 | $-0.55 | ||
| Q2 25 | $-0.36 | $-0.23 | ||
| Q1 25 | $-1.35 | $2.10 | ||
| Q4 24 | $-0.76 | $0.30 | ||
| Q3 24 | $-0.71 | $-0.69 | ||
| Q2 24 | $-0.88 | $-0.27 | ||
| Q1 24 | $-0.95 | $1.72 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $82.0M | $1.3M |
| 総負債低いほど良い | — | $1.3B |
| 株主資本純資産 | $450.0M | — |
| 総資産 | $850.6M | $2.4B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $82.0M | $1.3M | ||
| Q3 25 | $62.9M | $405.0K | ||
| Q2 25 | $65.6M | $1.3M | ||
| Q1 25 | $58.0M | $3.9M | ||
| Q4 24 | $83.2M | $4.4M | ||
| Q3 24 | $30.1M | $3.2M | ||
| Q2 24 | $26.4M | $4.9M | ||
| Q1 24 | $27.0M | $4.4M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | $157.2M | $1.2B | ||
| Q2 25 | $157.0M | $1.2B | ||
| Q1 25 | $156.9M | $1.3B | ||
| Q4 24 | $157.0M | $1.3B | ||
| Q3 24 | $118.5M | $1.2B | ||
| Q2 24 | $118.0M | $1.2B | ||
| Q1 24 | $118.2M | $1.2B |
| Q4 25 | $450.0M | — | ||
| Q3 25 | $442.5M | — | ||
| Q2 25 | $458.3M | — | ||
| Q1 25 | $458.3M | — | ||
| Q4 24 | $503.1M | — | ||
| Q3 24 | $525.9M | — | ||
| Q2 24 | $546.0M | — | ||
| Q1 24 | $570.3M | — |
| Q4 25 | $850.6M | $2.4B | ||
| Q3 25 | $832.6M | $2.3B | ||
| Q2 25 | $837.2M | $2.3B | ||
| Q1 25 | $823.1M | $2.4B | ||
| Q4 24 | $893.3M | $2.4B | ||
| Q3 24 | $867.9M | $2.3B | ||
| Q2 24 | $882.0M | $2.3B | ||
| Q1 24 | $906.0M | $2.3B |
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $27.7M | $-47.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $16.8M | $-67.5M |
| FCFマージンFCF / 売上 | 7.6% | -18.2% |
| 設備投資強度設備投資 / 売上 | 4.9% | 5.3% |
| キャッシュ転換率営業CF / 純利益 | — | -1.04× |
| 直近12ヶ月FCF直近4四半期 | $-1.3M | $61.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $27.7M | $-47.7M | ||
| Q3 25 | $12.4M | $41.8M | ||
| Q2 25 | $11.6M | $95.5M | ||
| Q1 25 | $-18.4M | $40.1M | ||
| Q4 24 | $23.7M | $8.8M | ||
| Q3 24 | $11.7M | $36.8M | ||
| Q2 24 | $9.0M | $61.4M | ||
| Q1 24 | $-18.6M | $75.1M |
| Q4 25 | $16.8M | $-67.5M | ||
| Q3 25 | $2.5M | $27.7M | ||
| Q2 25 | $4.5M | $80.9M | ||
| Q1 25 | $-25.1M | $20.8M | ||
| Q4 24 | $15.2M | $-15.1M | ||
| Q3 24 | $6.3M | $17.7M | ||
| Q2 24 | $-360.0K | $46.8M | ||
| Q1 24 | $-29.1M | $60.6M |
| Q4 25 | 7.6% | -18.2% | ||
| Q3 25 | 1.2% | 13.1% | ||
| Q2 25 | 2.2% | 31.1% | ||
| Q1 25 | -13.0% | 3.5% | ||
| Q4 24 | 7.0% | -4.0% | ||
| Q3 24 | 3.2% | 8.5% | ||
| Q2 24 | -0.2% | 18.4% | ||
| Q1 24 | -15.4% | 12.2% |
| Q4 25 | 4.9% | 5.3% | ||
| Q3 25 | 4.8% | 6.7% | ||
| Q2 25 | 3.5% | 5.6% | ||
| Q1 25 | 3.5% | 3.3% | ||
| Q4 24 | 4.0% | 6.4% | ||
| Q3 24 | 2.7% | 9.1% | ||
| Q2 24 | 4.7% | 5.8% | ||
| Q1 24 | 5.6% | 2.9% |
| Q4 25 | — | -1.04× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
SPH
| Propane | $326.4M | 88% |
| Other Sales Revenue Net | $19.9M | 5% |
| Fuel Oil And Refined Fuels | $18.2M | 5% |
| Natural Gas And Electricity | $5.9M | 2% |
| Wholesale | $4.1M | 1% |
